Cinemark (CNK) Reports Q3 Earnings: What Key Metrics Have to Say

31.10.24 14:30 Uhr

Werte in diesem Artikel
Aktien

30,64 EUR -0,27 EUR -0,87%

For the quarter ended September 2024, Cinemark Holdings (CNK) reported revenue of $921.8 million, up 5.4% over the same period last year. EPS came in at $1.19, compared to $0.61 in the year-ago quarter.The reported revenue represents a surprise of +3.37% over the Zacks Consensus Estimate of $891.75 million. With the consensus EPS estimate being $0.58, the EPS surprise was +105.17%.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.Here is how Cinemark performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts: Average ticket price - U.S. Operating Segment: $9.98 versus the three-analyst average estimate of $9.71. Average ticket price - International Operating Segment: $3.74 versus $3.75 estimated by three analysts on average. Concession revenues per patron - U.S. Operating Segment: $7.97 compared to the $7.48 average estimate based on three analysts. Concession revenues per patron - International Operating Segment: $2.97 compared to the $2.91 average estimate based on three analysts. Revenue- International Operating Segment- Admissions: $85.20 million compared to the $86.41 million average estimate based on two analysts. The reported number represents a change of -8.8% year over year. Revenue- U.S. Operating Segment- Admissions: $375.20 million versus the two-analyst average estimate of $365.11 million. The reported number represents a year-over-year change of +7.1%. Revenue- U.S. Operating Segment- Other: $42.20 million compared to the $64.63 million average estimate based on two analysts. The reported number represents a change of -34.2% year over year. Revenue- U.S. Operating Segment- Concession: $299.60 million versus the two-analyst average estimate of $281.06 million. The reported number represents a year-over-year change of +11.8%. Revenue- International Operating Segment- Other: $12.20 million versus the two-analyst average estimate of $26.05 million. The reported number represents a year-over-year change of -55%. Revenue- Admissions: $460.40 million compared to the $452.34 million average estimate based on six analysts. The reported number represents a change of +3.7% year over year. Revenue- Other: $94.10 million versus the six-analyst average estimate of $88.29 million. The reported number represents a year-over-year change of +3.2%. Revenue- Concession: $367.30 million versus $351.14 million estimated by six analysts on average. Compared to the year-ago quarter, this number represents a +8.1% change. View all Key Company Metrics for Cinemark here>>>Shares of Cinemark have returned +11.4% over the past month versus the Zacks S&P 500 composite's +1% change. The stock currently has a Zacks Rank #2 (Buy), indicating that it could outperform the broader market in the near term.5 Stocks Set to DoubleEach was handpicked by a Zacks expert as the #1 favorite stock to gain +100% or more in 2024. While not all picks can be winners, previous recommendations have soared +143.0%, +175.9%, +498.3% and +673.0%.Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor.Today, See These 5 Potential Home Runs >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Cinemark Holdings Inc (CNK): Free Stock Analysis ReportTo read this article on Zacks.com click here.Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

Ausgewählte Hebelprodukte auf Cinemark

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Cinemark

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu Cinemark Holdings Inc

Analysen zu Cinemark Holdings Inc

DatumRatingAnalyst
07.01.2019Cinemark OutperformImperial Capital
11.07.2018Cinemark OutperformImperial Capital
22.01.2018Cinemark BuyB. Riley FBR, Inc.
10.01.2018Cinemark OutperformRBC Capital Markets
25.09.2017Cinemark Sector PerformRBC Capital Markets
DatumRatingAnalyst
07.01.2019Cinemark OutperformImperial Capital
11.07.2018Cinemark OutperformImperial Capital
22.01.2018Cinemark BuyB. Riley FBR, Inc.
10.01.2018Cinemark OutperformRBC Capital Markets
07.08.2017Cinemark OutperformBarrington Research
DatumRatingAnalyst
25.09.2017Cinemark Sector PerformRBC Capital Markets
17.04.2017Cinemark Sector PerformRBC Capital Markets
07.04.2017Cinemark NeutralWedbush Morgan Securities Inc.
03.04.2017Cinemark Mkt PerformFBR & Co.
27.02.2017Cinemark Sector PerformRBC Capital Markets
DatumRatingAnalyst

Keine Analysen im Zeitraum eines Jahres in dieser Kategorie verfügbar.

Eventuell finden Sie Nachrichten die älter als ein Jahr sind im Archiv

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Cinemark Holdings Inc nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"